Cargando…
Temporary Knockdown of p53 During Focal Limb Irradiation Increases the Development of Sarcomas
Approximately half of patients with cancer receive radiotherapy and, as cancer survivorship increases, the low rate of radiation-associated sarcomas is rising. Pharmacologic inhibition of p53 has been proposed as an approach to ameliorate acute injury of normal tissues from genotoxic therapies, but...
Autores principales: | Daniel, Andrea R., Su, Chang, Williams, Nerissa T., Li, Zhiguo, Huang, Jianguo, Lopez, Omar, Luo, Lixia, Ma, Yan, Campos, Lorraine da Silva, Selitsky, Sara R., Modliszewski, Jennifer L., Liu, Siyao, Hernansaiz-Ballesteros, Rosa, Mowery, Yvonne M., Cardona, Diana M., Lee, Chang-Lung, Kirsch, David G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697056/ https://www.ncbi.nlm.nih.gov/pubmed/37982576 http://dx.doi.org/10.1158/2767-9764.CRC-23-0104 |
Ejemplares similares
-
Both CD8 and CD4 T cells contribute to immunosurveillance preventing the development of neoantigen-expressing autochthonous sarcomas
por: Himes, Jonathon E., et al.
Publicado: (2023) -
Investigating a chimeric anti-mouse PDGFRα antibody as a radiosensitizer in primary mouse sarcomas
por: Song, Erin J., et al.
Publicado: (2019) -
Tracing Tumor Evolution in Sarcoma Reveals Clonal Origin of Advanced Metastasis
por: Tang, Yuning J., et al.
Publicado: (2019) -
Atrx deletion impairs CGAS/STING signaling and increases sarcoma response to radiation and oncolytic herpesvirus
por: Floyd, Warren, et al.
Publicado: (2023) -
Generation and comparison of CRISPR-Cas9 and Cre-mediated genetically engineered mouse models of sarcoma
por: Huang, Jianguo, et al.
Publicado: (2017)